摘要
天冬氨酸蛋白酶、半胱氨酸蛋白酶和氨肽酶是与人血红蛋白降解及红细胞浸润与破裂过程息息相关的恶性疟原虫蛋白酶。由于抗疟药物的耐药性和寄生虫的自然选择的,我们必须寻求新的作用靶点以使药物达到治疗疟疾的目的。本文总结了蛋白酶和血红蛋白降解抑制剂的研究进展。此外,本文还概括了in silico 生物学预测抗疟药物的靶点、平衡选择和药物-蛋白质相互作用等内容。
关键词: 血红蛋白降解,天冬氨酸蛋白酶,半胱氨酸蛋白酶,药物靶点,疟疾,多态性。
图形摘要
Current Drug Targets
Title:Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets
Volume: 16 Issue: 10
Author(s): Tabish Qidwai
Affiliation:
关键词: 血红蛋白降解,天冬氨酸蛋白酶,半胱氨酸蛋白酶,药物靶点,疟疾,多态性。
摘要: Plasmepsins, falcipains and aminopeptidases are Plasmodium falciparum proteases involved in human host hemoglobin degradation and other processes like erythrocyte invasion and rupture. Antimalarial drug resistance and natural selection in parasite are important reasons that create the urgent need of novel targets and lead compounds to overcome the burden of malaria. This report explored progress of the study covering proteases and their inhibitors specific to hemoglobin degradation. Additionally, in silico predicted antimalarial targets, balancing selection and drug-protein interaction are included.
Export Options
About this article
Cite this article as:
Tabish Qidwai , Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets, Current Drug Targets 2015; 16 (10) . https://dx.doi.org/10.2174/1389450116666150304104123
DOI https://dx.doi.org/10.2174/1389450116666150304104123 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Can Lipoprotein-associated Phospholipase A<sub>2</sub> be Used as a Predictor of Long-term Outcome in Patients with Acute Coronary Syndrome?
Current Cardiology Reviews Hemin Treatment Abrogates Monocrotaline-Induced Pulmonary Hypertension
Medicinal Chemistry Dose Sparing of CpG Oligodeoxynucleotide Vaccine Adjuvants by Nanoparticle Delivery
Current Drug Delivery Animal Models of Lung Fibrosis
Current Respiratory Medicine Reviews Nardilysin, A Basic Residues Specific Metallopeptidase That Mediates Cell Migration and Proliferation
Protein & Peptide Letters Snake Venom Metalloproteinases: Structure, Mechanism and Induced Diseases
Current Chemical Biology From Amino Acids to Proteins as Targets for Metal-based Drugs
Current Drug Metabolism Gene Therapy as a Novel Pharmaceutical Intervention for Stroke
Current Pharmaceutical Design Update on the Development of microRNA and siRNA Molecules as Regulators of Cell Physiology
Recent Patents on DNA & Gene Sequences Design and Synthesis of Novel 1,3-Dioxane-2-carboxylic Acid Derivatives as PPARα/γ Dual Agonists
Letters in Drug Design & Discovery Sepsis, Coagulation and Anticoagulants
Endocrine, Metabolic & Immune Disorders - Drug Targets Microvascular Endothelial Dysfunction in Obesity and Hypertension
Current Pharmaceutical Design Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU Environment
Current Pharmaceutical Design Metabolic Control of Glia-Mediated Neuroinflammation
Current Alzheimer Research Topical Application of Escherichia coli Particles Over-Producing Pathogen-Derived Antigens as a Simple Vaccination Modality in Compliance with Evolutionary Medicine
Infectious Disorders - Drug Targets Preface [Hot Topic:Inflammatory Markers and Mediators: Emerging Therapeutic Targets in Diabetes, Cardiovascular and Metabolic Disorders (Guest Editor: Samuel Dagogo-Jack, MD)].
Current Drug Targets Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis
Current Pharmaceutical Design Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer
Current Pharmaceutical Design Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders
Current Pharmaceutical Design Pathophysiology of Acute and Infected Pancreatitis
Infectious Disorders - Drug Targets